Abstract
During tha past decade a better understanding of the natural history of ovarian carcinoma and the availability of adjuvant therapy have greatly expanded the usefulness of surgical treatment. Newer developments in surgical management include extended surgical staging and surgical cytoreduction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dembo, A.J., Bush, R.S., Beale, F.A., Bean, H.A., Pringle, J.F., Sturgeon, J. 1979. Ovarian carcinoma: Improved survival following abdominopelvic irradiation in patients with a completed pelvic operation. Am. J. Obstet. Gynecol. 134:793–800.
Piver, M.S., Barlow, J.J., Lele, S.B. 1978. Incidence of subclinical metastases in stage I and II ovarian carcinoma. Obstet. Gynecol. 52:100–104.
Smith J.P. and Day, T.G. 1979. Review of ovarian cancer at the University of Texas systems cancer center, M.D. Anderson Hospital and Tumor Institute. Am. J. Obstet. Gynecol. 135:984–993.
Munnell, E.W. 1967. The changing prognosis and treatment in cancer of the ovary. Am. J. Obstet. Gynecol. 100:790–805.
Griffiths, C.T. 1979. The Ovary. In Kistner, R.W. ed. Gynecology Principles and Practice, Chicago. The Year Book Medical Publishers.
Griffiths, C.T. and Fuller, A.F, Jr.: Intensive surgical and chemotherapeutic management of advanced ovarian cancer. Surgical Clinics of North America 58:131–142.
Fuller, A.F., Jr. and Griffiths, C.T. 1979. Ovarian cancer cachexia - surgical interactions. Gynecol. Oncol. 8: 301–310.
Parker, R.T., Parker, C.H. and Wiobanks, G.D. 1970. Cancer of the ovary. Am. J. Obstet. Gynecol. 108:878–888.
Aure, J.C., Joag, K. and Kolstad, P. 1971. Clinical and histologic studies of ovarian carcinoma. Obstet. Gynecol. 37:1–9, 1971.
Declos, L. and Quinlan, E.J. 1969. Malignant tumors of the ovary managed with postoperative megavoltage irradiation. Radiology 93:659–663.
Griffiths, C. T., Grogan, R. H. and Hall, T. C. 1972. Advanced ovarian cancer: Primary treatment with surgery, radiotherapy and chemotherapy. Cancer 29:1–7.
Griffiths, C.T. 1975. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Symposium on ovarian cancer. National Cancer Institute Monographs 42:101–104.
Hacker, N.F., Berek, J.S., Lagasse, L.D., Neiberg, R.K. and Llashoff, R.M. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet. Gynecol. (In Press).
Young, R.C., Chabner, B.A., Hubbard, W.P., Fisher, R.I., Bener, R.A., Anderson, T., Simon, R.M., Canellos, G.P. and Dita, V.T. 1978. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy. N. Eng. J. Med. 299:1261–1266.
Wharton, J.T. and Herson, J. 1981. Surgery for common epithelial tumors of the ovary. Cancer 48:582–589.
Greco, F.A., Julian, C.G., Richardson, R.C., Burnett, L., Hande, K.R. and Oldham, R.K. 1981. Advanced ovarian cancer: Brief intensive combination chemotherapy and second-look operation. Obstet. Gynecol. 58:199–206.
van Lindert, A.C.M., Alsbach, G.P.J., Barents, J., Heintz, A.P.M. and Kooyman, C. 1983. The abdominal radical tumor reduction procedure. In: Heintz, A.P.M., Griffiths, C.T., Trimbos, J.B. eds. Surgery in Gynecological Oncology. Martinus Nijhoff.
Griswold, D.P., Jr., Schabel, F.M., Jr., Wilcox, W.S., Simpson-Herron, L. and Skipper, H.E. 1968. Success and failure in the treatment of solid tumors. 1. Effects of cyclophosphamide (NSC 0 26271) on primary and metastatic plasmacytoma in the hamster. Cancer Chemother. Rep. 52: 345–387.
Schabel, F.M., Jr. 1969. The use of tumor growth kinetics in planning ‘curative’ chemotherapy of advanced solid tumors. Cancer Res. 29:2384–2389.
Shackney, S.E., McCormack, G.W., Cuchural, G.J., Jr. 1978. Growth rate patterns of solid tumors and their relation to responsiveness to therapy. Am. Intern. Med. 89:107–121.
Goldie, J.H. and Coldman, A.J. 1979. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 63:1727–1733.
Parker, L.M., Griffiths, C.T., Yankee, R.A., Canellos, G.P., Gelman, R., Knapp, R.C., Richman, C.M., Tobias, J.S., Weiner, R.S. and Frei, E. 1980. III: Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma. Cancer 46:669–674.
Wharton, J.T., Rutledge, F., Smith, J.P., Herson, J. and Hodge, M.P. 1979. Hexamethylmelamine: An evaluation of its role in the treatment of ovarian cancer. Am.J. Obstet. Gynecol. 133:833–844.
Gershenson, D.M., Wharton, J.T., Herson, T., Edwards, C.L. and Rutledge, F.M. 1981. Single agent cis-platinum therapy for advanced ovarian cancer. Obstet. Gynecol. 58:487–496.
Griffiths, C.T., Parker, L.M. and Fuller, A.F. 1979. Role of cytoreductive surgical treatment in themanagement of advanced ovarian cancer. Cancer Treat Rep. 63:235–240.
Berek, J.S., Hacker, N.F., Lagasse, L.D., Neiberg, R.K. and Elashoff, R.M. 1983. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet. Gynecol. 61:189–193.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Griffiths, C.T. (1984). New Developments in the Surgical Treatment of Ovarian Cancer. In: Heintz, A.P.M., Griffiths, C.T., Trimbos, J.B. (eds) Surgery in Gynecological Oncology. Developments in Oncology, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6750-2_22
Download citation
DOI: https://doi.org/10.1007/978-94-009-6750-2_22
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-6752-6
Online ISBN: 978-94-009-6750-2
eBook Packages: Springer Book Archive